Navigation Links
FDA Panel Votes for Tougher Curbs on Vicodin, Other Painkillers
Date:1/27/2013

By Amanda Gardner
HealthDay Reporter

FRIDAY, Jan. 25 (HealthDay News) -- A U.S. Food and Drug Administration advisory panel voted Friday to place tougher restrictions on prescription painkillers containing hydrocodone, potentially moving medications such as Vicodin into the same class as narcotics such as Oxycontin and Percocet.

Vicodin (hydrocodone plus acetaminophen) and other hydrocodone-containing drugs remain widespread targets for abuse, and the U.S. Drug Enforcement Administration has long requested that the FDA advisory panel undertake the review. The panel spent two days discussing the issue before voting on Friday afternoon, the Associated Press reported.

Currently, the medications are classified as Schedule III drugs but the DEA wants them placed within the more tightly controlled Schedule II designation, alongside painkillers such as Oxycontin and Percocet.

The FDA is not required to follow the recommendations of its advisory panels, but it typically does.

The issue has become a contentious one.

Supporters of a move to Schedule II status point to tragic deaths and suicides that have been the result of misuse of these prescription drugs.

But, opponents of that tougher classification fear that tightening access to the drugs would mean that people who really need them to ease pain will not be able to get them.

"This is really a decision of access versus diversion [for non-medical use]," explained Dr. Lynn Webster, president-elect of the American Academy of Pain Medicine, who said his organization was not necessarily in favor of or opposed to reclassification.

However, "it will have an impact on a lot of patients who have been receiving them for some time for legitimate purposes" if these drugs are reclassified, Webster added.

Dr. Andrew Kolodny, president of Physicians for Responsible Opioid Prescribing, called such concerns "completely bogus."

"Even if w
'/>"/>

Copyright©2012 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. U.S. Panel Rejects Ovarian Cancer Screening
2. FDA Panel Gives Blessing to New Weight-Loss Drug
3. FDA Panel to Consider At-Home HIV Test
4. FDA Panel Backs At-Home HIV Test
5. Screen All Adults for Obesity: U.S. Panel
6. Few Patients Should Get Metal-on-Metal Hip Implants, FDA Panel Says
7. Expert Panel Suggests PSA Test May Benefit Some Men
8. Expert panel calls for new research approach to prevent youth violence
9. U.S. Panel Rejects Ovarian Cancer Screens for Low-Risk Women
10. CDC Panel: All Pregnant Women Should Get Whooping Cough Shot
11. FDA Panel Considers 1st Drug for Chronic Fatigue Syndrome
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
FDA Panel Votes for Tougher Curbs on Vicodin, Other Painkillers
(Date:9/18/2014)... 2014 NexCore Group has opened its ... by Todd Varney and Justin Pawlak, will allow the ... the benefits and best practices of NexCore’s national healthcare ... local project delivery resources. , With a total ... across the country over the past several years to ...
(Date:9/18/2014)... and young adults who,ve been mentored may be more ... greater responsibility and independence early on in their career, ... having a mentor provides a clear benefit well into ... an associate professor of sociology at North Carolina State ... In conducting the study, published online recently in the ...
(Date:9/18/2014)... to develop broadly effective vaccines to prevent the spread ... limited progress has been made along these lines, there ... most people from these devastating diseases. , So ... working? , At Caltech, Nobel Laureate David Baltimore and ... way. Whereas vaccines introduce substances such as antigens into ...
(Date:9/18/2014)... Greensboro, NC (PRWEB) September 18, 2014 ... it’s also Domestic Violence Awareness Month. And the Centers ... Survey tells a scary story. , According to the ... a fourth of men in the U.S. experience some ... an intimate relationship. The same survey shows that about ...
(Date:9/18/2014)... New York, NY (PRWEB) September 18, 2014 ... retailer in NY, is now offering a 65-80% discount ... , including a whopping 71% off on its 14K ... $2,669, this diamond band can now be bought for ... band is 406147. , Talking about this diamond band, ...
Breaking Medicine News(10 mins):Health News:NexCore Group Opens Regional Office in Orlando, Florida 2Health News: Mentors May Steer Young People Toward More Rewarding Careers 2Health News:A new way to prevent the spread of devastating diseases 2Health News:A new way to prevent the spread of devastating diseases 3Health News:A new way to prevent the spread of devastating diseases 4Health News:A new way to prevent the spread of devastating diseases 5Health News:What you should know about domestic violence 2Health News:What you should know about domestic violence 3Health News:What you should know about domestic violence 4Health News:What you should know about domestic violence 5Health News:ItsHot.com Now Offering 65-80% Discount on its Striking Collection of Diamond Wedding Bands 2
... satisfaction scores at,outpatient health care facilities are on the ... Inc. The 2008 Outpatient Pulse Report: Patient,Perspectives on ... driver for improvement in patient services. The report,includes ... more than,1,200 outpatient care facilities nationwide last year. , ...
... New research has found that the availability of ... emergency room can significantly increase the number of stroke ... the study, conducted at North Shore Medical Center (NSMC)-Salem ... the annual meeting of the Radiological Society of North ...
... San Diego, December 2, 2008 As the connection ... clearer and legislation was passed to reduce such passive ... in the January 2009 issue of the American ... of California, San Francisco, Partners Healthcare, Boston and Columbia ...
... Cells shut down and stop dividing when their DNA ... so as to prevent damaged DNA from leading to ... study, published in this week,s issue of PLoS ... down they also spew proteins into their surrounding environment. ...
... Harnessing miRNA natural gene repressors for anticancer therapy ... Cancer Center, New York, have developed a new approach ... and used this to mediate effective anticancer therapy in ... are powerful natural repressors of gene expression. In the ...
... Tampa Beneficiaries for Par and Poker Celebrity Challenge for Charity , ... The Joyner-Walker Foundation today named the Kid,s Charity of Tampa Bay, ... beneficiaries for the 2009 Par and Poker Celebrity Challenge for Charity ... "It is only appropriate that events like this give ...
Cached Medicine News:Health News:Outpatient Service Facilities Face Increasing Competition - Patient Perceptions More Important Than Ever 2Health News:Portable CT increases chance of stroke survival and recovery 2Health News:Escape cancer, but age sooner? The dark side of the tumor suppressing process 2Health News:JCI online early table of contents: Dec. 1, 2008 2Health News:JCI online early table of contents: Dec. 1, 2008 3Health News:JCI online early table of contents: Dec. 1, 2008 4Health News:Celebrity Event Gives Local Non-Profits a Reason to be Thankful 2
(Date:9/18/2014)... SAN DIEGO , Sept. 18, 2014 /PRNewswire/ ... today announced that the U.S. Food and Drug ... patient enrollment and dosing of PEGPH20 in SWOG,s ... is designed to evaluate Halozyme,s investigational drug PEGPH20 ... FOLFIRINOX chemotherapy (mFOLFIRINOX) in patients with metastatic pancreatic ...
(Date:9/18/2014)... and MELBOURNE, Australia , Sept. ... Biopharma today announced the appointments of Dr. Ashraf ... D.V.M ., M.S., to its Board of Directors. Dr. ... Affairs Finance at Genentech and Chief Financial Officer for ... as Vice President and Global Head of Business Development ...
(Date:9/18/2014)... SYDNEY , Sept. 18, 2014 Australian ... an important US trial of its MiStat™ prostate cancer ... Administration (FDA) regulatory approval upon completion. Minomic,s ... identifying the presence of a proprietary biomarker known as ... surface of prostate cancer cells. Researchers ...
Breaking Medicine Technology:SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 2SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 3SWOG To Resume Clinical Trial Of Halozyme's PEGPH20 In Combination With Modified FOLFIRINOX For Advanced Pancreatic Cancer 4Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 2Nexvet Appoints Ashraf Hanna and Joseph McCracken to Board of Directors 3Minomic Launches US Pilot Study of MiStat(TM) Novel Prostate Cancer Screening Technology 2
... , SUNNYVALE, Calif. , Feb 11 ... second fiscal quarter ended December 31, 2009 . , Upon ... ended December 31, 2009 , the company began recognizing revenue under ... April 2009 . Total revenue recognized under GAAP in our most ...
... Mesa Laboratories, Inc. (Nasdaq: MLAB ) today reported sales ... December 31, 2009 . , Highlights: , ... Nine month cash flow provided by operations exceeded $4,882,000 ... six month period over the prior six months. , ...
Cached Medicine Technology:Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 2Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 3Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 4Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 5Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 6Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 7Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 8Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 9Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 10Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 11Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 12Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 13Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 14Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 15Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 16Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 17Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 18Pharmacyclics Reports Second Quarter Fiscal 2010 Financial Results 19Mesa Labs Reports Quarterly Sales and Earnings 2Mesa Labs Reports Quarterly Sales and Earnings 3Mesa Labs Reports Quarterly Sales and Earnings 4Mesa Labs Reports Quarterly Sales and Earnings 5Mesa Labs Reports Quarterly Sales and Earnings 6
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: